When studying DC subsets (CD1c+ myeloid DCs and CD304+ plasmacytoid DCs) in LN tissue it appeared that frequencies are comparable between RA-risk individuals and healthy controls, but increased in RA patients (29). This evidence concerns the gene CD1C and rheumatoid arthritis.